Status:
COMPLETED
Damage and Renal Clearance of Glycocalyx in Cardiac Surgery
Lead Sponsor:
Miguel Ayala León
Collaborating Sponsors:
Instituto Nacional de Cardiologia Ignacio Chavez
Conditions:
Glycocalyx
Cardio-Renal Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The glycocalyx is a component of the vascular endothelium that currently plays a relevant role in the modified Starling theory. The manipulation of the heart during cardiac surgery stimulates the rel...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Patients who underwent cardiac surgery for a single valve change or replacement
Exclusion
- Stage 3 renal failure patients
- Patients with a previous diagnosis of hematological malignancy
- Patients undergoing pulmonary valve change surgery.
- Patients undergoing Bentall and Bono surgery.
- Patients Undergoing Coronary Artery Bypass Surgery
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04332952
Start Date
August 1 2017
End Date
December 31 2017
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Beneficencia Española de Puebla
Puebla City, Mexico, 72090